Total Payments
$1,028
2024 Payments
$125.81
Companies
7
Transactions
27
Medicare Patients
252
Medicare Billing
$78,252
Payment Breakdown by Category
Food & Beverage$1,028 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,028 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $360.44 | 3 | $0 (2022) |
| Alkermes, Inc. | $224.07 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $139.31 | 7 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $125.81 | 1 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $86.29 | 4 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $64.40 | 6 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.16 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.81 | 1 | Teva Pharmaceuticals USA, Inc. ($125.81) |
| 2022 | $353.32 | 3 | Neurocrine Biosciences, Inc. ($254.25) |
| 2021 | $231.19 | 2 | Alkermes, Inc. ($125.00) |
| 2019 | $14.32 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14.32) |
| 2018 | $153.15 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($124.99) |
| 2017 | $150.69 | 10 | Valeant Pharmaceuticals North America LLC ($86.29) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $125.81 | General |
| Category: Neurology | ||||||
| 12/13/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $99.07 | General |
| Category: CNS | ||||||
| 10/20/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $125.62 | General |
| Category: Neuropsychiatry | ||||||
| 02/08/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $128.63 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $106.19 | General |
| Category: NEUROLOGY | ||||||
| 04/09/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 01/29/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: Lower GI | ||||||
| 09/24/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Lower GI | ||||||
| 06/19/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/27/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: Lower GI | ||||||
| 04/18/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Lower GI | ||||||
| 02/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/02/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2017 | Valeant Pharmaceuticals North America LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/03/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Lower GI | ||||||
| 09/08/2017 | Valeant Pharmaceuticals North America LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/21/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Lower GI | ||||||
| 06/05/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/31/2017 | Valeant Pharmaceuticals North America LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/24/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: Lower GI | ||||||
| 03/24/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 127 | $14,672 | $9,109 |
| 2022 | 2 | 87 | 361 | $42,302 | $23,549 |
| 2021 | 2 | 69 | 355 | $41,372 | $23,525 |
| 2020 | 2 | 62 | 335 | $38,632 | $22,070 |
Total Patients
252
Total Services
1,178
Medicare Billing
$78,252
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 114 | $12,540 | $7,810 | 62.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 13 | $2,132 | $1,299 | 60.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 313 | $34,430 | $19,159 | 55.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 40 | 48 | $7,872 | $4,390 | 55.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 312 | $34,320 | $19,559 | 57.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 33 | 43 | $7,052 | $3,965 | 56.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 302 | $33,220 | $19,046 | 57.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 27 | 33 | $5,412 | $3,024 | 55.9% |
About Dr. Joel Solomon, MD
Dr. Joel Solomon, MD is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881600120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Solomon, MD has received a total of $1,028 in payments from pharmaceutical and medical device companies, with $125.81 received in 2024. These payments were reported across 27 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,028).
As a Medicare-enrolled provider, Solomon has provided services to 252 Medicare beneficiaries, totaling 1,178 services with total Medicare billing of $78,252. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Providence, RI
- Active Since 07/31/2006
- Last Updated 05/16/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1881600120
Products in Payments
- INGREZZA (Drug) $360.44
- ARISTADA (Drug) $224.07
- UCERIS (Drug) $175.99
- UZEDY (Drug) $125.81
- Amitiza (Drug) $78.65
- XIFAXAN (Drug) $31.02
- XIFAXANIBSD (Drug) $18.59
- Trintellix (Drug) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Dr. James Greer, Md, MD
Psychiatry — Payments: $727,742
Psychiatry $727,742
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Psychiatry $43,650
Brian Ackerman
Psychiatry — Payments: $9,878
Psychiatry $9,878
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Psychiatry $6,302
Kazi Salahuddin, Md, MD
Psychiatry — Payments: $4,840
Psychiatry $4,840
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723
Psychiatry $4,723